Position in PFE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$286,990,183
-$25,777,043 QoQ
Shares Held
11,918,197
+7.0% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#54
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $4,134,092,265 across 9 Drug Manufacturers - General names. PFE ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
758,740 | $910,055,594 | |
| 2 | ABBV |
AbbVie Inc.
|
3,565,119 | $897,126,545 | |
| 3 | JNJ |
Johnson & Johnson
|
1,966,109 | $499,332,702 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,459,893 | $437,122,881 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
7,244,630 | $417,435,580 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,373,993 | $305,058,100 | |
| 7 | PFE |
Pfizer Inc
This page
|
11,918,197 | $286,990,183 | |
| 8 | AMGN |
Amgen Inc
|
580,049 | $210,047,343 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,990,183 | 11,918,197 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $312,767,226 | 11,138,434 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $245,779,010 | 9,870,643 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $290,435,436 | 11,398,565 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $246,071,947 | 10,151,483 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $188,309,116 | 7,431,299 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $169,203,485 | 6,377,817 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $130,181,178 | 4,498,313 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $57,041,343 | 2,038,647 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $74,804,093 | 2,695,643 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $102,174,903 | 3,548,972 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $143,666,600 | 4,331,221 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $194,448,896 | 5,301,224 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $249,519,662 | 6,115,678 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $320,114,009 | 6,247,346 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $317,344,150 | 7,251,923 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $399,612,284 | 7,621,825 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $428,591,146 | 8,278,755 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $501,196,086 | 8,487,656 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $433,530,907 | 10,079,770 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $405,439,418 | 10,353,407 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $322,296,754 | 8,895,853 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $338,952,185 | 9,208,155 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $358,919,150 | 9,779,823 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $234,767,015 | 7,179,412 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $235,807,230 | 7,224,496 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||